P3 Health Partners Inc. General form of registration statement for all companies including face-amount certificate companies

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2021

Dec. 31, 2020


	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Net Loss Attributable to Controlling Interests	$	(31,366,517)	$	(16,706,718)	$	(77,700,292)	$	(27,734,136)

Weighted Average Member Units		68,980,596		66,322,878		68,159,532		65,633,949

Basic and Diluted Loss per Member Unit	$	(0.45)	$	(0.25)	$	(1.14)	$	(0.42)


	2018		2019		2020
Net Loss Attributable to Controlling Interests	$	(43,801,295)	$	(35,009,263)	$	(41,074,505)
Weighted Average Member Units		24,602,085		47,587,945		65,833,962
Basic and Diluted Loss per Member Unit	$	(1.78)	$	(0.74)	$	(0.62)

At September 30, 2021, the Class A common stock reflected in the condensed balance sheets are reconciled in the following table:


Gross proceeds	$	316,250,000
Less:
Proceeds allocated to Public Warrants		(10,857,917)
Class A common stock issuance costs		(6,593,548)
Plus:
Accretion of carrying value to redemption value		17,451,465
Class A common stock subject to possible redemption	$	316,250,000

The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts):


	Three Months Ended				Nine Months Ended
	September 30, 2021				September 30, 2021
	Class A		Class B		Class A		Class B
Basic and diluted net income (loss) per common stock
Numerator:
Allocation of net income (loss), as adjusted	$	3,900,575	$	950,132	$	(665,697)	$	(188,517)
Denominator:
Basic and diluted weighted average stock outstanding		32,457,500		7,906,250		27,345,147		7,743,819
Basic and diluted net income (loss) per common stock	$	0.12	$	0.12	$	(0.02)	$	(0.02)